Kidney Disease
Researchers create comprehensive map of human kidney to study disease progression
Researchers funded by the NIH developed a comprehensive atlas of the human kidney to examine disease progression and recovery.
Peer group for immigrants with kidney disease shows positive results
A peer support group for immigrants lacking permanent legal status with kidney failure receiving emergency dialysis had high recruitment, retention and delivery rates, suggesting it may be suitable for patient use, according to a study.
Kidney therapy decision aid receives high acceptability marks from patients, caregivers
A new educational patient-decision aid received high acceptability ratings from older adults with kidney disease and their caregivers, according to published data.
Care needed in selecting dietary and herbal supplements for patients with kidney disease
Complementary and alternative medicine is a multibillion-dollar industry made popular by people looking for improved well-being. This effort can be done with or without guidance from a health care provider.
FDA approves Veklury for COVID-19 treatment in patients with severe renal impairment
The FDA has approved the use of Veklury for the treatment of COVID-19 in patients with severe renal impairment, including those on dialysis, according to a press release from drug manufacturer Gilead Sciences Inc.
Q&A: $10 million initiative seeks to address misuse of race in medicine
The Doris Duke Foundation has launched a new initiative that aims to address the misuse of race in clinical equations.
Patients’ desire to learn, help others with ESKD outweighs payment in study enrollment
Patients’ desire to help others and learn more about their kidney disease rated higher than financial incentives when it came to study enrollment, recently published data show.
DNA methylation markers may help predict diabetic kidney disease progression
Using DNA methylation markers in blood samples may help predict the progression of diabetic kidney disease in patients with type 2 diabetes, recent data suggests.
Medicare enrollees with kidney disease have ‘disproportionately higher’ medical costs
Medicare Advantage enrollees with mildly reduced kidney function and accelerated eGFR decline have disproportionately higher medical costs than other patients, data show.
Discussion, use of decision aids can improve mental health of patients with kidney disease
With May serving as Mental Health Awareness Month, Healio spoke with experts to discuss how nephrologists and dialysis staff can improve the mental health of patients with kidney disease.